BRPI1009345A2 - sistema de administracao de droga, uso de um sistema de administracao de droga, e, metodo pata tratar doencas - Google Patents
sistema de administracao de droga, uso de um sistema de administracao de droga, e, metodo pata tratar doencasInfo
- Publication number
- BRPI1009345A2 BRPI1009345A2 BRPI1009345A BRPI1009345A BRPI1009345A2 BR PI1009345 A2 BRPI1009345 A2 BR PI1009345A2 BR PI1009345 A BRPI1009345 A BR PI1009345A BR PI1009345 A BRPI1009345 A BR PI1009345A BR PI1009345 A2 BRPI1009345 A2 BR PI1009345A2
- Authority
- BR
- Brazil
- Prior art keywords
- delivery system
- drug delivery
- treating disease
- disease
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16094209P | 2009-03-17 | 2009-03-17 | |
EP09155383 | 2009-03-17 | ||
PCT/EP2010/053339 WO2010106046A1 (en) | 2009-03-17 | 2010-03-16 | Macrocyclic lactone drug delivery system |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI1009345A2 true BRPI1009345A2 (pt) | 2016-03-08 |
Family
ID=40941503
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI1009345A BRPI1009345A2 (pt) | 2009-03-17 | 2010-03-16 | sistema de administracao de droga, uso de um sistema de administracao de droga, e, metodo pata tratar doencas |
Country Status (11)
Country | Link |
---|---|
US (1) | US9345686B2 (pt) |
EP (1) | EP2408432A1 (pt) |
JP (1) | JP2012520847A (pt) |
KR (1) | KR20120006987A (pt) |
CN (1) | CN102355891A (pt) |
AR (1) | AR075846A1 (pt) |
AU (1) | AU2010224918A1 (pt) |
BR (1) | BRPI1009345A2 (pt) |
CA (1) | CA2755753A1 (pt) |
MX (1) | MX2011009678A (pt) |
WO (1) | WO2010106046A1 (pt) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2608660B1 (en) * | 2010-07-30 | 2020-04-01 | Ceva Sante Animale | Compositions for treating heartworm infestation |
BR112013002175A2 (pt) * | 2010-07-30 | 2016-10-25 | Ceva Sante Animale | método para controlar a infestação por vermes do coração, composição de uma droga veterinária e kit útil para o controle de uma infestação parasitária por verme do coração em uma cobaia não humana |
CL2014000989A1 (es) * | 2014-04-17 | 2014-10-17 | Univ Santiago Chile | Dispositivo subdermal de liberacion prolongada y lenta para prevencion, tratamiento y monitoreo de parasitos, que comprende al menos una lactona macrociclica tal como ivermectina y/o dormectina, opcionalmente nanoparticulas o microparticulas de zeolita, una matriz polimerica y medios de monitoreo, dentro de un circuito integrado. |
US10406336B2 (en) * | 2016-08-03 | 2019-09-10 | Neil S. Davey | Adjustable rate drug delivery implantable device |
US10188602B2 (en) | 2016-09-29 | 2019-01-29 | Gesea Biosciences Inc. | Bioerodible implant for long-term drug delivery and associated methods of manufacture and use |
MX2020012459A (es) * | 2018-05-24 | 2021-04-28 | Celanese Eva Performance Polymers Llc | Dispositivo implantable para liberacion sostenida de un compuesto de farmaco macromolecular. |
AU2019275406A1 (en) | 2018-05-24 | 2020-07-16 | Celanese Eva Performance Polymers Llc | Implantable device for sustained release of a macromolecular drug compound |
WO2020006000A1 (en) * | 2018-06-25 | 2020-01-02 | Titan Pharmaceuticals, Inc. | Implants for release of lipophilic or amphiphilic pharmaceutical substances |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3950360A (en) | 1972-06-08 | 1976-04-13 | Sankyo Company Limited | Antibiotic substances |
US3984564A (en) | 1972-06-08 | 1976-10-05 | Sankyo Company Limited | Antibiotic substances B-41, their production and their use as insecticides and acaricides |
US4144317A (en) | 1975-05-30 | 1979-03-13 | Alza Corporation | Device consisting of copolymer having acetoxy groups for delivering drugs |
SE434277B (sv) | 1976-04-19 | 1984-07-16 | Merck & Co Inc | Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis |
US4199569A (en) | 1977-10-03 | 1980-04-22 | Merck & Co., Inc. | Selective hydrogenation products of C-076 compounds and derivatives thereof |
ES8800986A1 (es) | 1985-07-27 | 1987-12-01 | Pfizer | Un procedimiento para la produccion de un nuevo derivado de avermectina |
US4916154A (en) | 1986-09-12 | 1990-04-10 | American Cyanamid Company | 23-Imino derivatives of LL-F28249 compounds |
IL98599A (en) | 1990-06-28 | 1995-06-29 | Merck & Co Inc | Stable salts of "4-deoxy-" 4-epi-methylamino abramectin and insecticides containing them |
US5399717A (en) | 1993-09-29 | 1995-03-21 | Merck & Co., Inc. | Glycosidation route to 4"-epi-methylamino-4"-deoxyavermectin B1 |
AUPR602501A0 (en) | 2001-06-29 | 2001-07-26 | Smart Drug Systems Inc | Sustained release pharmaceutical composition |
AUPR610501A0 (en) | 2001-07-04 | 2001-07-26 | Smart Drug Systems Inc | Treatment of parasitic disease |
AUPR951501A0 (en) * | 2001-12-14 | 2002-01-24 | Smart Drug Systems Inc | Modified sustained release pharmaceutical system |
TWI290837B (en) * | 2004-03-24 | 2007-12-11 | Organon Nv | Drug delivery system |
BRPI0504244A (pt) | 2005-09-29 | 2007-09-25 | Clarion Biociencias Ltda | implantes subdérmicos de etilenovilacetato (eva) e polydimethylsiloxane (silicone) que consiste na utilização de eva ou silicone para uso como matriz plástica endectocida, associado ou não a um ectoparasiticida e/ou igr, para confecções de implantes subdérmicos para utilização em bovinos, cães e gatos e respectivo método de produção |
-
2010
- 2010-03-16 CN CN2010800125011A patent/CN102355891A/zh active Pending
- 2010-03-16 AR ARP100100817A patent/AR075846A1/es unknown
- 2010-03-16 WO PCT/EP2010/053339 patent/WO2010106046A1/en active Application Filing
- 2010-03-16 EP EP10709491A patent/EP2408432A1/en not_active Withdrawn
- 2010-03-16 CA CA2755753A patent/CA2755753A1/en not_active Abandoned
- 2010-03-16 AU AU2010224918A patent/AU2010224918A1/en not_active Abandoned
- 2010-03-16 US US13/256,264 patent/US9345686B2/en not_active Expired - Fee Related
- 2010-03-16 MX MX2011009678A patent/MX2011009678A/es not_active Application Discontinuation
- 2010-03-16 KR KR1020117022800A patent/KR20120006987A/ko not_active Application Discontinuation
- 2010-03-16 JP JP2012500218A patent/JP2012520847A/ja not_active Withdrawn
- 2010-03-16 BR BRPI1009345A patent/BRPI1009345A2/pt not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP2408432A1 (en) | 2012-01-25 |
JP2012520847A (ja) | 2012-09-10 |
CN102355891A (zh) | 2012-02-15 |
WO2010106046A1 (en) | 2010-09-23 |
KR20120006987A (ko) | 2012-01-19 |
MX2011009678A (es) | 2011-09-30 |
AR075846A1 (es) | 2011-04-27 |
US20120052108A1 (en) | 2012-03-01 |
US9345686B2 (en) | 2016-05-24 |
AU2010224918A1 (en) | 2011-10-06 |
CA2755753A1 (en) | 2010-09-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI1009345A2 (pt) | sistema de administracao de droga, uso de um sistema de administracao de droga, e, metodo pata tratar doencas | |
BRPI0917030A2 (pt) | sistema de liberação de fármaco contendo progestina | |
BRPI0913214A2 (pt) | sistema de fornecimento de drogas transdérmico estabilizado | |
BRPI0917250A2 (pt) | sistema para detecção de tecido em um paciente, sistema para detectar característica de tecido em um paciente | |
BRPI1006885A2 (pt) | sistema de completação utilizável com um poço, e método utilizável com um poço | |
BRPI1014139A2 (pt) | sistema de liberação de fármacos compreendendo polioxazolina e um agente biotivo. | |
BRPI1014771A2 (pt) | dispositivo de dispensação de droga, método para carregar um dispositivo de dispensação de droga, e, sistema para carregar um dispositivo de dispensação de droga | |
BRPI0916328A2 (pt) | sistema e método para redução de fratura, bem como método para formação de um sistema para redução de fratura | |
BRPI1005998A2 (pt) | metodo para prover o suporte de pressao a um paciente, sistema de suporte de pressao e metodo para prover suporte de pressao a um paciente | |
BRPI1016147A2 (pt) | sistema intrauterino para uso no tratamento de uma condição médica, e, método para a fabricação de um sistema intrauterino | |
BRPI1009004A2 (pt) | método para integrar diagnóstico e tratamento para tecidos internos, e, sistema para integrar diagnóstico e tratamento para tecidos internos | |
BRPI1014975A2 (pt) | sistema de entrega de implante | |
BRPI0925314A2 (pt) | Sistema e método para preparar uma quantidade predeterminada de bebida, cápsula, e, uso de uma cápsula. | |
BRPI1008076A2 (pt) | sistema, método e aparelho para implementar implantes dentários | |
BR112012025956A2 (pt) | sistema médico, aparelho e método | |
BRPI1006922A2 (pt) | sistema para descarte de medicação | |
BR112014021103A8 (pt) | anticorpo, composição farmacêutica, droga de combinação, dna, método de tratamento e uso de anticorpo | |
BRPI1010950A2 (pt) | método para preparação de emulsão carregada de fármaco. | |
BR112014002621A2 (pt) | anticorpo, composição farmacêutica, combinação farmacêutica, dna e método de tratamento | |
DK2398500T3 (da) | Glutathion-baseret lægemiddelafgivelsessystem | |
BR112012000888A2 (pt) | sistema e método para iniciar um sistema operacional multiambiente | |
BRPI1016218A2 (pt) | sistema, e, método | |
BRPI1013630A2 (pt) | sistema, e método | |
BRPI1014894A2 (pt) | método, e sistema | |
BR112014001962A2 (pt) | dispositivo, sistema e método para restauração prostodôntica |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A E 6A ANUIDADES |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2369 DE 31-05-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |